FDA Clears First of Robotic Exoskeleton for Multiple Sclerosis
The wearable EksoNR robotic exoskeleton is the first FDA-cleared exoskeleton for use in the rehabilitation of patients with multiple sclerosis.
FDA Approvals
source https://www.medscape.com/viewarticle/975528?src=rss
FDA Approvals
source https://www.medscape.com/viewarticle/975528?src=rss
Comments
Post a Comment